Ara mostrant els elements 1-1 de 1

    New targets in tumor angiogenesis to block tumor re-growth and therapeutic resistance 

    Bassani, Nicklas (Data de defensa: 2017-12-15)

    Antiangiogenic drugs are used clinically for treatment of different types of cancers and in the case of renal cell carcinoma (RCC) are now standard first-line treatments (Rini, 2009). Nevertheless, these agents mainly serve ...